Adage Capital Partners’s Processa Pharmaceuticals PCSA Stock Holding History
Bought
Maintained
Sold
Other funds holding PCSA
SFCM
Adage Capital Partners's PCSA Position: Q3 2026 in Review
Adage Capital Partners opened a new position in Processa Pharmaceuticals (PCSA) in Q3 2026: 3,275,493 shares worth $5.37M. The stake represents 0.01% of the portfolio and ranks #830 among its holdings.
18 funds tracked by Wall St. Rank hold PCSA as of Q3 2026.
- Adage Capital Partners held 3,275,493 shares of Processa Pharmaceuticals worth $5.37M as of Q3 2026.
- Processa Pharmaceuticals was a new Adage Capital Partners position in Q3 2026.
- Processa Pharmaceuticals made up 0.01% of Adage Capital Partners's portfolio in Q3 2026, its #830 holding.
- 18 funds tracked by Wall St. Rank held Processa Pharmaceuticals as of Q3 2026.
Based on Adage Capital Partners's 13F filing for Q3 2026, filed 16 Nov 2026.